Market Place
Sourcing Support
Genentech shifts Hemlibra marketing focus to patient stories
20 Apr 2026 //
FIERCE PHARMA
ATUM Welcomes Gavin Barnard, Ph.D., As Chief Scientific Officer
16 Apr 2026 //
GLOBENEWSWIRE
Genentech Walks The Walk In Lupus As Sponsor Of Annual Event
26 Mar 2026 //
FIERCE PHARMA
Genentech CEO Says Aiming for Tolerable, Affordable Obesity drugs
17 Mar 2026 //
REUTERS
Delayed Notice Reveals 141 More Layoffs From Genentech In 2025
09 Feb 2026 //
BIOSPACE
Genentech Cut At Least 489 Jobs Last Year, New Filing Reveals
06 Feb 2026 //
FIERCE PHARMA
Roche Scales Genentech`s NC Obesity Drug Site To $2B
21 Jan 2026 //
FIERCE PHARMA
Roche Commits $100M To Keep Its GLP-1 Structure Sound
06 Jan 2026 //
FIERCE BIOTECH
Genentech Announces Agreement With U.S. Government
20 Dec 2025 //
BUSINESSWIRE
Caris, Genentech Collaborate on Novel Cancer Targets
16 Dec 2025 //
PR NEWSWIRE
Genentech Uncovers `Hidden Gems` In Latest #Msvisibility Drive
09 Dec 2025 //
FIERCE PHARMA
Genentech To Unveil Hematology Portfolio Data at ASH 2025
03 Nov 2025 //
BUSINESSWIRE
Genentech Lets 118 Staffers Go In Another HQ Layoff Round
29 Oct 2025 //
FIERCE BIOTECH
Ventus Pharma Collaborates With Genentech On Small-Molecule
21 Oct 2025 //
BUSINESSWIRE
Genentech Expands Xofluza Access For Flu Season
16 Oct 2025 //
BUSINESSWIRE
Genentech`s 1st DTC Program Centers On Discounted Xofluza
16 Oct 2025 //
FIERCE PHARMA
Genentech Appoints New Marketing Chief
18 Sep 2025 //
FIERCE PHARMA
Bicycle Cuts Staff as Genentech Ends R&D Pact
08 Aug 2025 //
FIERCE BIOTECH
Global Alzheimer Platform, Genentech Partner for Research Access
28 Jul 2025 //
GLOBENEWSWIRE
Genentech Downsizes by 87 as Priorities Shift
24 Jul 2025 //
BIOSPACE
Genentech Axes 87 Jobs in Latest HQ Layoffs Round
23 Jul 2025 //
FIERCE BIOTECH
Genentech Provides Update on Phase III Verona Study
16 Jun 2025 //
BUSINESSWIRE
NEJM: Single-dose Xofluza Reduces Influenza Transmission
25 Apr 2025 //
BUSINESSWIRE
Kineta sells Genentech, Merck deals to investor ahead of merger
11 Feb 2025 //
FIERCE BIOTECH
Genentech Itovebi Show Survival Benefit In HR+ve Breast Cancer
28 Jan 2025 //
BUSINESSWIRE
Genentech’s Itovebi Shows Survival Benefit in Breast Cancer
27 Jan 2025 //
BUSINESSWIRE
Genentech Reports Update on Phase III SKYSCRAPER-01 Study Results
26 Nov 2024 //
BUSINESSWIRE
Onco360 Named National Pharmacy Partner for Itovebi™
11 Nov 2024 //
GLOBENEWSWIRE
Genentech to Share Long-term Data at ASH 2024 Hematology
05 Nov 2024 //
BUSINESSWIRE
Genentech’s Itovebi Shows Landmark Phase 3 Results in Breast Cancer
30 Oct 2024 //
BUSINESSWIRE
Roche`s Evrysdi Shows Positive Results In Children With SMA
14 Oct 2024 //
GLOBENEWSWIRE
Xofluza Phase III Results Reduce Influenza Virus Transmission
19 Sep 2024 //
BUSINESSWIRE
Genentech`s cancer restructure was made `for scientific reasons`: exec
10 Sep 2024 //
FIERCE BIOTECH
Genentech to Lay Off 93 in San Francisco
28 Aug 2024 //
BIOSPACE
Genentech to shut down cancer immunology department amid broader R&D rethink
19 Aug 2024 //
FIERCE BIOTECH
Genentech, ADA Plot Program To Improve Diabetes-Related Eye Health
07 Aug 2024 //
FIERCE PHARMA
Relay loses interest in SHP2 inhibitor after Genentech abandons collab
07 Aug 2024 //
FIERCE BIOTECH
Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz
05 Aug 2024 //
GLOBENEWSWIRE
Genentech`s Site Alliance Boosts Diverse Patient Enrollment
05 Aug 2024 //
FIERCE BIOTECH
Genentech takes to TikTok to push biomarker testing message
02 Aug 2024 //
FIERCE PHARMA
Genentech takes SMA song ‘Spaces’ to the White House for Disability Pride Month
30 Jul 2024 //
FIERCE PHARMA
Genentech sinks SHP2 pact, leaving Relay to race thinning field
17 Jul 2024 //
FIERCE BIOTECH
Roche to reintroduce eye implant med Susvimo 2 years after recall
08 Jul 2024 //
FIERCE PHARMA
Genentech Updates On Phase II/III SKYSCRAPER-06 Study In Lung Cancer
04 Jul 2024 //
BUSINESSWIRE
Inovalon and Genentech Study Reveals Racial Disparities in Liver Cancer Care
25 Jun 2024 //
GLOBENEWSWIRE
Genentech`s Columvi Extends Survival In R R DLBCL
14 Jun 2024 //
BUSINESSWIRE
Novartis, Roche unit and others face Italy antitrust probe over eye drug
07 Jun 2024 //
REUTERS
FDA Priority Review: Genentech`s Inavolisib For PIK3CA+ Breast Cancer
29 May 2024 //
BUSINESSWIRE
FDA Grants Genentech`s Inavolisib Breakthrough For PIK3CA Breast Cancer
21 May 2024 //
BUSINESSWIRE
Adaptimmune’s debt financing deal; Tenaya to cut workers
15 May 2024 //
ENDPTS
Genentech animated short spotlights docs` trust in Vabysmo
13 May 2024 //
FIERCE PHARMA
Alecensa approved as 1st adjuvant for ALK+ early lung cancer
18 Apr 2024 //
BUSINESSWIRE
Genentech’s Columvi Meets Primary Endpoint Ref. Diffuse Large B-Cell Lymphoma
15 Apr 2024 //
PRESS RELEASE
Genentech`s Columvi Meets DLBCL STARGLO Survival Endpoint
15 Apr 2024 //
BUSINESSWIRE
Genentech plans to cut 3% of workforce across several units, company says
10 Apr 2024 //
ENDPTS
Genentech is Broadway bound with latest campaign
07 Feb 2024 //
ENDPTS
Roche’s Genentech returns Alzheimer’s assets to AC Immune
22 Jan 2024 //
FIERCE BIOTECH
Genentech`s food allergy medication gets priority review nod from the FDA
20 Dec 2023 //
ENDPTS
Genentech confirms Magargee as permanent CEO
13 Dec 2023 //
PHARMAPHORUM
